Opinion
No. 22-37
10-03-2022
TEVA PHARMACEUTICALS USA, INC., Petitioner, v. GLAXO-SMITHKLINE LLC, et al.
The Solicitor General is invited to file a brief in this case expressing the views of the United States.
From Casetext: Smarter Legal Research
Teva Pharm. USA, Inc. v. Glaxo-Smithkline LLC
Supreme Court of the United States
Oct 3, 2022
143 S. Ct. 80 (2022)
Summaries of
Teva Pharm. USA, Inc. v. Glaxo-Smithkline LLC
Supreme Court of the United States
Oct 3, 2022
143 S. Ct. 80 (2022)
Case details for
Teva Pharm. USA, Inc. v. Glaxo-Smithkline LLC
Case Details
Full title:TEVA PHARMACEUTICALS USA, INC., Petitioner, v. GLAXO-SMITHKLINE LLC, et al.
Court:Supreme Court of the United States
Date published: Oct 3, 2022
Citations
143 S. Ct. 80 (2022)
214 L. Ed. 2d 10